
USFDA APPLICATION NUMBER - 208647 / DOSAGE - CAPSULE;ORAL - EQ 10MG BASE
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| ROSUVASTATIN CALCIUM(UNII: 83MVU38M7Q) (ROSUVASTATIN - UNII:413KH5ZJ73) | ROSUVASTATIN | 40mg | 20mg | 10mg | 5mg |
Inactive Ingredients
| Ingredient Name | Sun Pharmaceutical Industries, Inc. |
|---|---|
| AMMONIA(5138Q19F1X) | |
| BUTYL ALCOHOL(8PJ61P6TS3) | |
| CROSPOVIDONE(2S7830E561) | |
| D&C RED NO. 28(767IP0Y5NH) | |
| FD&C BLUE NO. 1(H3R47K3TBD) | |
| FD&C GREEN NO. 3(3P3ONR6O1S) | |
| FD&C RED NO. 3(PN2ZH5LOQY) | |
| FD&C RED NO. 40(WZB9127XOA) | |
| FERRIC OXIDE YELLOW(EX438O2MRT) | |
| FERROSOFERRIC OXIDE(XM0M87F357) | |
| GELATIN, UNSPECIFIED(2G86QN327L) | |
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |
| MAGNESIUM OXIDE(3A3U0GI71G) | |
| MANNITOL(3OWL53L36A) | |
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
| POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | |
| POTASSIUM HYDROXIDE(WZH3C48M4T) | |
| PROPYLENE GLYCOL(6DC9Q167V3) | |
| SHELLAC(46N107B71O) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR) | |
| SODIUM LAURYL SULFATE(368GB5141J) | |
| TITANIUM DIOXIDE(15FIX9V2JP) |